Arcturus Therapeutics Holdings (ARCT) Competitor Comparison
We are evaluating the key criteria listed to compare Arcturus Therapeutics Holdings (ARCT) against its competitors in the Biotechnology industry.
Market Capitalization
119 / 368Gross Profits
58 / 278Total Revenue
39 / 300EBITDA
21 / 337Free Cashflow
22 / 352Quick Ratio
218 / 357Earnings per Share
227 / 359Dividend yield
0 / 6Total Cash
109 / 358Performance 3 years
158 / 368Performance 5 years
79 / 368Performance 10 years
124 / 368Linearity 3 years
85 / 368Linearity 5 years
69 / 368Linearity 10 years
32 / 368Total Rank
148 / 368Dividend Rank
357 / 368Valuation Rank
70 / 368Piotroski Rank
11 / 368Muliplier Rank
275 / 368Total Revenue - ARCT ranking 39 / 300
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.